Clinical trial Recruiting at 1 site Observational Ages 18 and up

Norepinephrine Bolus to Tackle Post-Induction Hypotension in Heart Failure Patients Under General Anesthesia

Official title: Evaluation of Norepinephrine in the Management of General Anesthesia-Induced Arterial Hypotension in Chronic Heart Failure Patients in the Operating Room.

Run by University Hospital, Toulouse · NCT06350929 · Data updated 2026-11-12

A diluted norepinephrine bolus is tested to see if it improves cardiac output in adults with chronic heart failure who develop arterial hypotension after anesthesia is started.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorUniversity Hospital, Toulouse
Academic / other
Locations1 site (Toulouse)
StatusRecruiting
StartedOctober 17, 2024
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedNovember 5, 2026
Trial IDNCT06350929 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with chronic heart failure (LVEF ≤40%), scheduled for surgery under general anesthesia, with planned invasive monitoring and postoperative ICU care, and who develop arterial hypotension after anesthesia induction.

Probably not a fit

Patients without arterial hypotension after induction or those without invasive monitoring plans may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study looks at whether a diluted norepinephrine bolus can improve cardiac output in patients with chronic heart failure who experience arterial hypotension after induction of general anesthesia. Cardiac output monitoring will be performed using the Starling SV Sebac device. The study population is adults with heart failure (LVEF ≤40%) undergoing planned surgery under general anesthesia, with invasive hemodynamic monitoring in place and postoperative ICU follow-up. The investigation aims to describe the hemodynamic impact of norepinephrine and inform perioperative management in this high-risk group.

Why it matters

Potential benefit: If successful, the approach could help stabilize blood pressure and improve perfusion during surgery in heart failure patients.

How similar studies have gone: Previous practices using norepinephrine for intraoperative hypotension are common, but data on its impact on cardiac output in chronic heart failure patients are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients
* Heart failure patients with left ventricular failure with a ventricular ejection fraction less than or equal to 40% evaluated by trans-thoracic echocardiography less than a year ago and specifying in particular the patient's filling pressures at the state stable.
* Patients under treatment adapted to the level of heart failure according to the 2021 European Society of Cardiology recommendations.
* Scheduled surgery under general anesthesia.
* Invasive hemodynamic monitoring planned by the anesthetist-resuscitator (irrespective of potential inclusion in the protocol): arterial catheter and central venous line for measurement of CVP (central venous pressure).
* Postoperative monitoring planned in intensive care or intensive care
* Presence of controlled mechanical ventilation with tidal volumes between 8 and 10 ml/kg of ideal weight.
* Presence of arterial hypotension after induction of general anesthesia, and before surgical stimulation.
* Patient affiliated to a social security scheme or equivalent
* No opposition from the patient.

Exclusion Criteria:

* Chronic heart failure patients with right ventricular failure.
* Patients presenting signs of acute pulmonary edema, Pulmonary arterial hypertension (PAH), severe valvular disease, intracardiac shunt.
* Patients operated on under general anesthesia but maintaining spontaneous ventilation.
* Patients with respiratory compliance disorders with compliances greater than 30 cm of water.
* Patients with intra-abdominal hypertension.
* Patients with supraventricular or ventricular arrhythmia.
* Patients treated with catecholamines prior to the procedure.
* Patients operated on for urgent surgeries
* Patient under guardianship, curatorship or safeguard of justice
* Pregnant or breastfeeding women.

Where it's running

  • CHU Toulouse Rangueil
    Toulouse, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.